Downstaging for hepatocellular cancer: harm or benefit?
Sign Up to like & getrecommendations! Published in 2017 at "Translational gastroenterology and hepatology"
DOI: 10.21037/tgh.2017.11.18
Abstract: Downstaging of hepatocellular carcinoma (HCC) to enable liver transplantation has become an area of intense interest and research. It may allow a curative option in patients outside widely accepted transplantation criteria, with outcomes that, in… read more here.
Keywords: downstaging hepatocellular; harm benefit; hepatocellular cancer; gastroenterology ... See more keywords